
    
      This is a multicenter, controlled, randomized, monocular trial evaluating the safety and
      effectiveness of the Bausch & Lomb DVisc40 dispersive OVD compared to the Alcon VISCOAT®
      dispersive OVD when used in cataract surgery. Subjects will be randomized to one of the two
      treatment groups in a 1:1 ratio (DVisc40:VISCOAT®).
    
  